Showing results (61-70 of 299) with videos related to

Sort By:
Pageof 30
Translational Lung Cancer Research|February 11, 2021
Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case seriesNathaniel J Myall, Amy Q Lei, Heather A Wakelee
Clinical Lung Cancer|July 28, 2006
Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup TrialHeather A Wakelee, Joan H Schiller, David R Gandara
The Oncologist|May 11, 2017
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed TherapyChristina S Baik, Nathaniel J Myall, Heather A Wakelee
Clinical Lung Cancer|December 10, 2021
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on OsimertinibMaya N White, Andrew J Piper-Vallillo, Rebecca M Gardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2023
Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of BiomarkersJulie Tsu-Yu Wu, Heather A Wakelee, Summer S Han
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation TrialClara Y H Choi, Heather A Wakelee, Joel W Neal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
One allele's loss is another's gain: alterations of NKX2-8 in non-small cell lung cancerJoel W Neal, Alice T Shaw
Current Treatment Options in Oncology|August 3, 2010
Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and HhJoel W Neal, Lecia V Sequist
Translational Lung Cancer Research|July 18, 2017
Novel systemic therapy against malignant pleural mesotheliomaMichael R Mancuso, Joel W Neal
Pageof 30